Skip to main content
Top
Published in: Gastric Cancer 4/2019

01-07-2019 | Gastric Cancer | Original Article

A novel TNM staging system for gastric cancer based on the metro-ticket paradigm: a comparative study with the AJCC-TNM staging system

Authors: Jun Lu, Zhi-Fang Zheng, Wei Wang, Jian-Wei Xie, Jia-Bin Wang, Jian-Xian Lin, Qi-Yue Chen, Long-Long Cao, Mi Lin, Ru-Hong Tu, Zhi-Wei Zhou, Chang-Ming Huang, Chao-Hui Zheng, Ping Li

Published in: Gastric Cancer | Issue 4/2019

Login to get access

Abstract

Background

The metro-ticket prognostic tool for hepatocellular carcinoma has been proven to predict outcome, but a similar concept has not been investigated for GC. The objective of the current study was to apply the principles of the metro-ticket paradigm to develop a novel TNM staging system (nTNM) for gastric cancer (GC).

Methods

The nTNM considered the distance from the origin on a Cartesian plane incorporating the pN (x-axis) and pT (y-axis) stages. GC patients undergoing radical resection at Fujian Medical University Union Hospital (FMUUH) (n = 4267) were included. The nTNM was validated using 2 external cohorts from the Sun Yat-sen University Cancer Center (SYSUCC) (n = 1800) and Surveillance, Epidemiology, and End Results (SEER) (n = 3227) databases.

Results

nTNM classes with the same distance from the origin have same stage; the stage increases with this distance. Among all patients, 48.0% (n = 2049) were restaged in the nTNM compared with the 7th edition of the AJCC-TNM classification; 26.2% (n = 1116) were downstaged in the nTNM compared with the 8th edition. The nTNM provides significant survival differences between stages (all P < 0.001). The survival difference between stages IB and IIA was especially large for the nTNM (P < 0.001) compared to the 7th and 8th editions (P = 0.073). The concordance index and hazard ratio increased successively with the nTNM stage. Similar findings were observed in both external cohorts.

Conclusion

Compared with the AJCC-TNM classification, the nTNM for GC is easier to remember and provides some improvements; therefore, the nTNM may be considered for adoption in future editions of the AJCC-TNM classification.
Appendix
Available only for authorised users
Literature
1.
go back to reference Amin MB, Edge S, Greene F, et al. AJCC cancer staging manual, 8th edn. New York: Springer; 2017. Amin MB, Edge S, Greene F, et al. AJCC cancer staging manual, 8th edn. New York: Springer; 2017.
2.
go back to reference In H, Solsky I, Palis B, Langdon-Embry M, Ajani J, Sano T. Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the national cancer database. Ann Surg Oncol. 2017;24(12):3683–91.CrossRef In H, Solsky I, Palis B, Langdon-Embry M, Ajani J, Sano T. Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the national cancer database. Ann Surg Oncol. 2017;24(12):3683–91.CrossRef
3.
go back to reference Lu J, Zheng ZF, Xie JW, et al. Is the eighth edition of the AJCC TNM staging system sufficiently reasonable for all patients with noncardia gastric cancer? A 12,549 patient international database study. Ann Surg Oncol. 2018;25(7):2002–11.CrossRef Lu J, Zheng ZF, Xie JW, et al. Is the eighth edition of the AJCC TNM staging system sufficiently reasonable for all patients with noncardia gastric cancer? A 12,549 patient international database study. Ann Surg Oncol. 2018;25(7):2002–11.CrossRef
4.
go back to reference Ji X, Bu Z, Yan Y, et al. The 8th edition of the American Joint Committee on Cancer tumor-node-metastasis staging system for gastric cancer is superior to the 7th edition: results from a Chinese mono-institutional study of 1663 patients. Gastric Cancer. 2017;24(4):643–52. Ji X, Bu Z, Yan Y, et al. The 8th edition of the American Joint Committee on Cancer tumor-node-metastasis staging system for gastric cancer is superior to the 7th edition: results from a Chinese mono-institutional study of 1663 patients. Gastric Cancer. 2017;24(4):643–52.
5.
go back to reference Lu J, Zheng CH, Cao LL, et al. The effectiveness of the 8th American Joint Committee on Cancer TNM classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 7th and 8th editions. Eur J Surg Oncol. 2017;43(12):2349–56.CrossRef Lu J, Zheng CH, Cao LL, et al. The effectiveness of the 8th American Joint Committee on Cancer TNM classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 7th and 8th editions. Eur J Surg Oncol. 2017;43(12):2349–56.CrossRef
6.
go back to reference Fang W, Huang K, Chen M, et al. Comparative study of the 7th and 8th AJCC editions for gastric cancer patients after curative surgery. PLOS One. 2017;12(11):e187626. Fang W, Huang K, Chen M, et al. Comparative study of the 7th and 8th AJCC editions for gastric cancer patients after curative surgery. PLOS One. 2017;12(11):e187626.
7.
go back to reference Mazzaferro V. Results of liver transplantation: With or without milan criteria? Liver Transplant. 2007;13(S2):S44–7.CrossRef Mazzaferro V. Results of liver transplantation: With or without milan criteria? Liver Transplant. 2007;13(S2):S44–7.CrossRef
8.
go back to reference Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10(1):35–43.CrossRefPubMed Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10(1):35–43.CrossRefPubMed
9.
go back to reference Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol. 1983;1(11):710–9.CrossRefPubMed Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol. 1983;1(11):710–9.CrossRefPubMed
10.
go back to reference Japanese GCA. Japanese classification of gastric carcinoma—2nd English Edition. Gastric Cancer. 1998;1(1):10–24.CrossRef Japanese GCA. Japanese classification of gastric carcinoma—2nd English Edition. Gastric Cancer. 1998;1(1):10–24.CrossRef
11.
go back to reference Japanese GCA. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14(2):101–12.CrossRef Japanese GCA. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14(2):101–12.CrossRef
12.
go back to reference Warneke VS, Behrens HM, Hartmann JT, et al. Cohort study based on the seventh edition of the TNM classification for gastric cancer: proposal of a new staging system. J Clin Oncol. 2011;29(17):2364–71.CrossRefPubMed Warneke VS, Behrens HM, Hartmann JT, et al. Cohort study based on the seventh edition of the TNM classification for gastric cancer: proposal of a new staging system. J Clin Oncol. 2011;29(17):2364–71.CrossRefPubMed
13.
go back to reference Marrelli D, Morgagni P, de Manzoni G, et al. Prognostic value of the 7th AJCC/UICC TNM classification of noncardia gastric cancer. Ann Surg. 2012;255(3):486–91.CrossRef Marrelli D, Morgagni P, de Manzoni G, et al. Prognostic value of the 7th AJCC/UICC TNM classification of noncardia gastric cancer. Ann Surg. 2012;255(3):486–91.CrossRef
14.
go back to reference Jung H, Lee HH, Song KY, Jeon HM, Park CH. Validation of the seventh edition of the American Joint Committee on Cancer TNM staging system for gastric cancer. Cancer Am Cancer Soc. 2011;117(11):2371–8. Jung H, Lee HH, Song KY, Jeon HM, Park CH. Validation of the seventh edition of the American Joint Committee on Cancer TNM staging system for gastric cancer. Cancer Am Cancer Soc. 2011;117(11):2371–8.
15.
16.
go back to reference Shi S, Hua J, Liang C, et al. Proposed modification of the 8th edition of the AJCC staging system for pancreatic ductal adenocarcinoma. Ann Surg. 2018:1. Shi S, Hua J, Liang C, et al. Proposed modification of the 8th edition of the AJCC staging system for pancreatic ductal adenocarcinoma. Ann Surg. 2018:1.
17.
go back to reference Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):i57–i63.CrossRef Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):i57–i63.CrossRef
18.
go back to reference Japanese GCA. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2):113–23.CrossRef Japanese GCA. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2):113–23.CrossRef
19.
go back to reference Lee KG, Lee HJ, Oh SY, et al. Is there any role of adjuvant chemotherapy for T3N0M0 or T1N2M0 gastric cancer patients in stage II in the 7th TNM but stage I in the 6th TNM System? Ann Surg Oncol. 2016;23(4):1234–43.CrossRefPubMed Lee KG, Lee HJ, Oh SY, et al. Is there any role of adjuvant chemotherapy for T3N0M0 or T1N2M0 gastric cancer patients in stage II in the 7th TNM but stage I in the 6th TNM System? Ann Surg Oncol. 2016;23(4):1234–43.CrossRefPubMed
20.
go back to reference Wang J, Dang P, Raut CP, et al. Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg. 2012;255(3):478–85.CrossRefPubMed Wang J, Dang P, Raut CP, et al. Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg. 2012;255(3):478–85.CrossRefPubMed
21.
go back to reference Rocken C, Behrens HM. Validating the prognostic and discriminating value of the TNM-classification for gastric cancer—a critical appraisal. Eur J Cancer. 2015;51(5):577–86.CrossRefPubMed Rocken C, Behrens HM. Validating the prognostic and discriminating value of the TNM-classification for gastric cancer—a critical appraisal. Eur J Cancer. 2015;51(5):577–86.CrossRefPubMed
22.
go back to reference Lin J, Lin J, Li P, et al. Which staging system better predicts 10-year survival for gastric cancer? A study using an international multicenter database. Eur J Surg Oncol. 2018;44(8):1205–11.CrossRefPubMed Lin J, Lin J, Li P, et al. Which staging system better predicts 10-year survival for gastric cancer? A study using an international multicenter database. Eur J Surg Oncol. 2018;44(8):1205–11.CrossRefPubMed
Metadata
Title
A novel TNM staging system for gastric cancer based on the metro-ticket paradigm: a comparative study with the AJCC-TNM staging system
Authors
Jun Lu
Zhi-Fang Zheng
Wei Wang
Jian-Wei Xie
Jia-Bin Wang
Jian-Xian Lin
Qi-Yue Chen
Long-Long Cao
Mi Lin
Ru-Hong Tu
Zhi-Wei Zhou
Chang-Ming Huang
Chao-Hui Zheng
Ping Li
Publication date
01-07-2019
Publisher
Springer Singapore
Published in
Gastric Cancer / Issue 4/2019
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-018-00904-w

Other articles of this Issue 4/2019

Gastric Cancer 4/2019 Go to the issue